Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2022 Earnings Call Transcript November 9, 2022
Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.14.
Operator: Good day, ladies and gentlemen. Welcome to the Lexicon Pharmaceuticals Inc. Third Quarter 2022 Earnings Conference Call. At this time all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. This call is being recorded on...
